Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant

Journal of Medical Microbiology

Volumn 49, Issue 10, 2000, Pages 917-928

  Kraiczy, P ^a   Hunfeld, K P ^a   Peters, S ^a   Wurzner, R ^a   Acker, G ^a   Wilske, B ^a   Brade, V ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C9; COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN; RNA;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BORRELIA AFZELII; BORRELIA INFECTION; COMPLEMENT SYSTEM; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL;

BORRELIA AFZELII;

EID: 0033798259     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-10-917     Document Type: Article

References (37)

1. Lyme disease
2. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not OspD or the 83-kilodalton antigen
3. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice
4. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA
5. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice
6. Outer surface protein C (OspC), but not p39, is a protective immunogen against a tick transmitted Borrelia burgdorferi challenge: Evidence for a conformational protective epitope in OspC
7. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against Borrelia burgdorferi infection
8. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection
9. Growth inhibitory and bactericidal efficacy of sera from Lyme borreliosis patients on B. burgdorferi strains
10. Lyme disease assay which detects killed Borrelia burgdorferi
11. In vitro inhibition of Borrelia burgdorferi growth by antibodies
12. Activity of sera from patients with Lyme disease against Borrelia burgdorferi
13. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi
14. European Borrelia burgdorferi isolated from human and ticks, culture conditions and antibiotic susceptibility
15. Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates
16. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies
17. Blood dentritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies
18. Characterization of outer membranes isolated from Borrelia burgdorferi, the Lyme disease spirochete
19. Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli
20. Ultrastructural surface alterations of Serratia marcescens after exposure to polymyxin B and/or fresh human serum
21. A low-viscosity epoxy resin embedding medium for electron microscopy
22. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy
23. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato
24. Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies
25. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibody to OspB
26. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein
27. The 39-kilodalton protein of Borrelia burgdorferi: A target for bactericidal human monoclonal antibodies
28. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex
29. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey
30. Complement-mediated in vitro bactericidal activity of monoclonal antibodies reactive with the outer-surface-protein OspB of Borrelia burgdorferi
31. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement
32. Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: A 'gold standard'?
33. Clinical comparison of borreliacidal-antibody test with indirect immunofluorescence and enzyme-linked immunosorbent assays for diagnosis of Lyme disease
34. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding
35. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi
36. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine
37. Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi